GSK1292263
GSK1292263 is a novel GPR119 agonist, showing potential for the treatment of type 2 diabetes. Phase 2.
| Trivial name | N/A |
| Catalog Number | S2149 |
| Molecular Formula | C23H28N4O4S |
| CAS# | 1032823-75-8 |
| Inchi | InChI=1S/C23H28N4O4S/c1-16(2)22-25-23(31-26-22)27-12-10-17(11-13-27)15-30-19-6-9-21(24-14-19)18-4-7-20(8-5-18)32(3,28)29/h4-9,14,16-17H,10-13,15H2,1-3H3 |
| Inchi Key | AYJRTVVIBJSSKN-UHFFFAOYSA-N |
| SMILES | CC(C)C1=NOC(=N1)N2CCC(CC2)COC3=CN=C(C=C3)C4=CC=C(C=C4)S(=O)(=O)C |
| Size | 10mg |
| Supplier Page | http://www.selleckchem.com/products/GSK1292263.html |
| Additional Information | https://file.selleck.cn/downloads/struct/GSK-1292263-chemical-structure-S2149.gif |